Your browser doesn't support javascript.
loading
[Clinical symptoms, diagnosis and treatment of multiple endocrine neoplasia type 1. Results of genetic screening in Hungarian patients]. / Az 1-es típusú multiplex endokrin neoplasia klinikai tünetei, diagnózisa és kezelése. A genetikai vizsgálatok hazai tapasztalatai.
Balogh, Katalin; Hunyady, László; Patócs, Attila; Valkusz, Zsuzsanna; Bertalan, Rita; Gergics, Péter; Majnik, Judit; Toke, Judit; Tóth, Miklós; Szucs, Nikolette; Gláz, Edit; Futo, László; Horányi, János; Rácz, Károly; Tulassay, Zsolt.
Afiliação
  • Balogh K; Semmelweis Egyetem, Altalános Orvostudományi Kar, II. Sz. Belgyógyászati Klinika, Budapest. balogh@bel2.sote.hu
Orv Hetil ; 146(43): 2191-7, 2005 Oct 23.
Article em Hu | MEDLINE | ID: mdl-16323565
ABSTRACT
Multiple endocrine neoplasia type 1 syndrome is an autosomal dominant disorder characterized by endocrinopathies involving the parathyroid glands, anterior pituitary gland, and pancreas. Also, it may be associated with foregut carcinoid, adrenocortical tumors and non-endocrine tumors. After reviewing the prevalence, genetic background, clinical symptoms, diagnosis and treatment of the disorder, the authors present their genetic screening method used for the detection of mutations of the MEN1 gene (prescreening of polymerase chain reaction amplified exons using temporal temperature gradient gel electrophoresis followed by direct DNA sequencing). Using this method, the authors identified disease-causing MEN1 gene mutations in 9 probands (small deletions in 2 cases, insertion in 2 cases, nonsense mutations in 2 cases and missense mutations in 3 cases). Of the 9 mutations, 4 proved to be novel mutation not reported in the literature. Family screening indicated de novo mutations in 2 probands. In addition to mutations, several sequence polymorphisms were also detected. The authors conclude that one of the major advantages of genetic screening in families with MEN1 syndrome was the identification of family members carrying the mutation who should be regularly screened for disease manifestations and those not carrying the mutation in whom clinical screening is unnecessary. Also, genetic screening may be useful in cases when MEN1 syndrome is suspected, but the clinical manifestations do not fully establish the diagnosis of MEN1 syndrome.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes Genéticos / Neoplasia Endócrina Múltipla Tipo 1 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Europa Idioma: Hu Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes Genéticos / Neoplasia Endócrina Múltipla Tipo 1 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Europa Idioma: Hu Ano de publicação: 2005 Tipo de documento: Article